Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market today. The firm’s initial public offering is looking to raise US$69.0 million and is expected to close on March 29, 2022.

The offering consists of 4.6 million common shares, upsized from 4.0 million shares, selling at US$15.00 per share. The company intends to use the proceeds to fund the clinical development and expansion of its drug candidate epetraborole, and for general corporate purposes, including working capital and operating expenses.

Cowen, SVB Leerink, and Evercore ISI act as the joint bookrunners for the said offering. The underwriters were granted a 30-day over-allotment option to purchase additional 690,000 shares at the same IPO price.

The Menlo Park-based biotech company is focused on developing epetraborole, an experimental oral treatment for patients with chronic non-tuberculous mycobacterial lung disease.

LOGO

Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Tech SPAC AxonPrime Infrastructure Acquisition Conducts US$150 Million IPO

Special purpose acquisition company AxonPrime Infrastructure Acquisition Corporation (Nasdaq: APMIU) started trading publicly on the...

Monday, August 16, 2021, 10:49:00 AM

Electric Vehicle Maker Rivian Prices Upsized US$11.9 Billion IPO

Start-up electric vehicle maker Rivian Automotive, Inc. (Nasdaq: RIVN) started trading on the Nasdaq Global...

Wednesday, November 10, 2021, 02:17:00 PM

Birkenstock Files For $8 Billion IPO

Birkenstock, the renowned German footwear company, took a significant step towards going public on Tuesday....

Wednesday, September 13, 2023, 10:36:00 AM

LNG Firm Excelerate Energy Launches IPO

Liquefied natural gas company Excelerate Energy is looking to go public on the New York...

Tuesday, April 5, 2022, 02:21:00 PM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM